ARTICLE | Financial News
Amylin up after Icahn discloses stake
May 17, 2008 12:42 AM UTC
Amylin (NASDAQ:AMLN) rose $1.52 to $32.15 on Friday after financier Carl Icahn disclosed in an SEC filing that he held a stake in the diabetes company. At March 31, Icahn held 6.3 million shares, or a...